Corient Private Wealth’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,296
Closed -$771K 2688
2025
Q3
$771K Buy
+29,296
New +$753K ﹤0.01% 1550
2025
Q1
Sell
-88,381
Closed -$2M 2338
2024
Q4
$2M Buy
88,381
+2,918
+3% +$63.3K ﹤0.01% 998
2024
Q3
$1.82M Buy
85,463
+10,349
+14% +$204K ﹤0.01% 1142
2024
Q2
$1.43M Buy
75,114
+23,152
+45% +$472K ﹤0.01% 1181
2024
Q1
$1M Sell
51,962
-14,172
-21% -$281K ﹤0.01% 1313
2023
Q4
$1.38M Buy
66,134
+41,139
+165% +$790K ﹤0.01% 1164
2023
Q3
$538K Sell
24,995
-2,956
-11% -$71.8K ﹤0.01% 1455
2023
Q2
$669K Sell
27,951
-2,000
-7% -$45.9K ﹤0.01% 1311
2023
Q1
$637K Buy
+29,951
New +$573K ﹤0.01% 1278

Other funds holding FMS

Corient Private Wealth's FMS Position: Q4 2025 in Review

Corient Private Wealth sold out of Fresenius Medical Care (FMS) in Q4 2025, closing a stake of 29,296 shares — an estimated $771K sold.

Corient Private Wealth first reported a position in FMS in Q1 2023 and held it in 9 quarters. The position peaked at $2M in Q4 2024. 214 funds tracked by Wall St. Rank hold FMS as of Q4 2025.

  • Corient Private Wealth reported no remaining Fresenius Medical Care position as of Q4 2025 after selling out during the quarter.
  • Corient Private Wealth sold 29,296 Fresenius Medical Care shares in Q4 2025, an estimated $771K.
  • Corient Private Wealth first reported a position in Fresenius Medical Care in Q1 2023 and held it in 9 quarters.
  • Corient Private Wealth's Fresenius Medical Care position peaked at $2M in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2025.

Based on Corient Private Wealth's 13F filing for Q4 2025, filed 19 Feb 2026.